CompaniesNammi Therapeutics
Nammi Therapeutics logo

Nammi Therapeutics

active
Los Angeles, CA, United States
Founded 2018
Website
About

Nanocarriers Targeting Tumors

Areas of Focus

Categories

NanotechDrug Delivery & FormulationSan Diego & Southern California
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

100

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
NCT06582017
Hover over trial bars to see details

Recent Trials

NCT06582017Lead Sponsor
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
PHASE1Recruiting
100 participants
Started: Aug 28, 2024 · Completed: May 30, 2028
Locations (1)
Headquarters
Los Angeles, CA, United States
Map

Loading map...